Shows the first high-resolution structure of an actin-disrupting drug, Latrunculin-A in association with actin. Capability of Latrunculin-A in rapidly, reversibly and specifically disrupting actin cytoskeleton. Creation of latrunculin-A compounds in cell-biology laboratories due to its efficacy; Comparison of the complexity of the mode of action of latrunculin and cytochalasin.